Hikma Pharmaceuticals Plc Director/PDMR Shareholding (3431E)
February 08 2018 - 7:41AM
UK Regulatory
TIDMHIK
RNS Number : 3431E
Hikma Pharmaceuticals Plc
08 February 2018
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Said Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Chairman and Chief Executive Officer
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Pledge by Darhold Limited by 6,000,000
the transaction Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in favour
of Morgan Stanley Bank, N.A. The
Chairman and Chief Executive is a
director of and shareholder in Darhold
Limited with an equity interest of
21.67%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 6,000,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 6,000,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Executive Vice Chairman
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Pledge by Darhold Limited by 6,000,000
the transaction Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in favour
of Morgan Stanley Bank, N.A. The
Executive Vice Chairman is a director
of and shareholder in Darhold Limited
with an equity interest of 10.92%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 6,000,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 6,000,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Mohammed 'Ali' Al-Husry
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Non-Executive Director
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Pledge by Darhold Limited by 6,000,000
the transaction Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in favour
of Morgan Stanley Bank, N.A. The
Non-Executive Director is a director
of and shareholder in Darhold Limited
with an equity interest of 8.01%.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 6,000,000
--- --------------------- ----------------------------------------
d) Aggregated Aggregated volume: 6,000,000
information Price: GBP0.00p
--- --------------------- ----------------------------------------
e) Date of the 7 December 2017
transaction
--- --------------------- ----------------------------------------
f) Place of the Amman
transaction
--- --------------------- ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDGDDGSGBGII
(END) Dow Jones Newswires
February 08, 2018 07:41 ET (12:41 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
